Single Agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study
Research in Oncology
doi 10.21608/resoncol.2007.372
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2007
Authors
Publisher
Egypts Presidential Specialized Council for Education and Scientific Research